Aloreidi Khalil, Gedela Maheedhar, Wabwire Godfrey, Mothapothula Uma M, Jha Lokesh
Department of Internal Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Sanford Hospitalists Clinic, Sioux Falls, South Dakota.
S D Med. 2018 Apr;71(4):168-170.
Hepatic hydrothorax (HH) occurs in 5-10 percent of patients with cirrhosis and usually develops in conjunction with ascites. We report a case of refractory right sided pleural effusion which turned out to be HH in the absence of ascites or previous history of cirrhosis. HH is thought to occur in isolation due to the superior absorptive capacity of the peritoneum as compared to the pleura. Diagnosis is usually clinical but can be confirmed by scintigraphic studies. The treatment is similar to that for ascites with transjugular intrahepatic portosystemic shunt (TIPS) being the most effective but it is associated with high rate of complications.
肝性胸水（HH）见于5%至10%的肝硬化患者，通常与腹水同时出现。我们报告一例难治性右侧胸腔积液病例，结果发现是HH，且无腹水或既往肝硬化病史。由于腹膜比胸膜具有更强的吸收能力，HH被认为可单独发生。诊断通常依靠临床症状，但可通过闪烁扫描研究得以证实。治疗方法与腹水相似，经颈静脉肝内门体分流术（TIPS）最为有效，但该方法并发症发生率较高。
